Dermatol. praxi. 2015;9(1):31-35

Advances in treating alopecia

MUDr.Hana Duchková, DrSc., MUDr.Marta Hašková
Kožní sanatorium s. r. o., Ústí nad Labem

The paper provides an overview of the clinical presentation, pathogenesis, and treatment of alopecia. Treatments for androgenetic

alopecia include topical minoxidil in both men and women and systemic finasteride in men. In progressive alopecia areata, systemic

corticosteroids are administered in a short term; in localized forms, topical corticosteroids, anthralin (cignolin) and diphencyprone, are

used. Pseudopelade – scarring irreversible alopecia represents the final stage of multiple different types of scarring alopecia that are

very difficult to treat. Histological and dermatoscopic examination helps identify different types of alopecia (1).

Keywords: alopecia, pathogenesis, classification, treatment

Published: March 16, 2015  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Duchková H, Hašková M. Advances in treating alopecia. Dermatol. praxi. 2015;9(1):31-35.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Wofl H. (SRN) 3. Přehled alopecií. Mezinárodní letní akademie praktické dermatologie, Mnichov, 21.-26. 7. 2013.
    2. European Dermatology Forum (EDF) "White Book) 2001, Bern, Switzerland. Hair disorders. 94-100.
    3. Futterweit W, Dunaif A, et al. The prevalence of hyperandrogenism in 109 mconsecutive female patients with difuse alopecia. J Am Acad Dermatol 1988; 19: 831-839. Go to original source... Go to PubMed...
    4. Norwood OT. Male pattern baldness classification and incidence. South Med J 1975; 68: 359-365. Go to original source... Go to PubMed...
    5. Ludwig E. Classification of the type of androgenetic alopecia (common baldnes) occuring in the female sex. Br J Dermatol 1977; 97: 247-254. Go to original source... Go to PubMed...
    6. Kantor J. Female alopecia. Investik Dermatol 2003; 121: 985. Go to original source... Go to PubMed...
    7. Rejnek J, Duchková H, a další. Studium vlivu obsahu cizorodých látek na životní prostředí.Kapitola 5. Sledování možné souvislosti mezi obsahem některých kovů v lidském organismu a výskytem některých druhů onemocnění. Stanovení obsahu železa, mědi a zinku ve vlasech. Grantový úkol na rok 1993.
    8. Duchková H, Hašková M. Androgenetická alopecie - diagnostika, diferenciální diagnostika, léčba. DERMA, 2013; 13(2): 3-9.
    9. Bienová M, Kučerová R. Dermatoskopická diagnostika alopecií. Čes-slov derm: 2014; 89(1): 1-52.
    10. Duchková H, Hašková M. Mezoterapie - alternativní léčba androgenetické alopecie. DERMA, 2013; 13(3): 3-7.
    11. Sperling LC, Lupton GP. Histopathology of non-scarring alopecia. J Cutan Pathol 1995; 22: 97-114. Go to original source... Go to PubMed...
    12. Sinclair R, Wewerinke M, Jolley D. Treatment of female pattern hair loss with oral antiandroges. Br J Dermatol 2005; 152: 466-473. Go to original source... Go to PubMed...
    13. Trueb RM. Finasteride treatment of patterned hair loss in normoandrogenic postmenopausal women. Dermatol 2004; 209: 202-207. Go to original source... Go to PubMed...
    14. Thai KE, Sinclair R. Finasteride for female androgenetic alopecia; Br J Dermatol 2002; 147: 812-813. Go to original source... Go to PubMed...
    15. Price VH, Menefee E. Quantitive estimation of hair growth. Androgenetic alopecia in women: efect of minoxidil. J Invet Dermatol 1990; 95: 683-687. Go to original source... Go to PubMed...
    16. Schmutz JL, Barbaud A, Trechot P. Alopecia and Mesotherapy. Ann Dermatol Venereol 2010; 137(4): 338-341. Go to original source... Go to PubMed...
    17. Kang JS, et al. The effect of CD34+ cell-containing autologous platelet-rich plasma injection on pattern hair loss: preliminary study. JEADV 2014; 28: 72-79. Go to original source... Go to PubMed...
    18. Říčař J. Nejčastější primární jizvící alopecie. Čes-slov derm 2012; 3: 81-124
    19. Georgala S, Katoulis AC, Befon A. Treatment of postmenopausal frontal fibrosing alopecia with oral dutasteride. J Am Acad Dermatol 2009; 61: 157-158. Go to original source... Go to PubMed...
    20. Zingernagel MS, Trueb RM. Fibrosing alopecia in a pattern distribution. Arch Dermatol 2000; 136: 205-211. Go to original source... Go to PubMed...
    21. Rácz E, Gho C, Moorman PW, Nordhoek Hegt V, Neumann HAM. Treatment of frontal fibrosing alopecia and lichen planopilaris: a systemic review. JEADV 2013; 27: 1461-1470. Go to original source... Go to PubMed...
    22. Katoulis A. Georgala S, Bozi E. Frontal fibrosing slopecia: Treatment with oral dutasteride and topical pimecrolimus. JEADV 2009; 23: 580-581. Go to original source... Go to PubMed...
    23. Kučerová R. Folliculitis decalvans. Česká dermatovenerologie 2013; 3(2): 106-109.
    24. Tobin DJ, Hann SK. Hair follicle structures targeted by antibodies in patiens with alopecia areata Arch Dermatol 1997; 133: 57-61. Go to original source... Go to PubMed...
    25. Alabdulkareem A, Abuhussein A, Okoro A. Severe alopecia areata treated with systemic cortocosteroids. Int J Dermatol 1998; 37: 622-628. Go to original source... Go to PubMed...
    26. Peeriard-Wlfensberg J. Pulse of methylprednisolone in alopecia areata. Dermatology 1993; 187: 282. Go to original source... Go to PubMed...
    27. Fiedler VC. Treatment resistent alopecia areata. Response to combination therapy with minoxidil plus anthralin. Arch dermatol 1990; 126-756. Go to original source...
    28. Cotellessa C. The use of topical diphencyclopropenone for the treatment of extensit alopecia areata. J Am Acad Dermatol. 2001; 44: 73. Go to original source... Go to PubMed...
    29. Ohlemeier MC, Trape H, Luger TA, Bohm M. Topical immunotherapy with diphenylcyclopropenone of patiens with alopecia areata - a largeretrospective study on 142 patients with a self-controlled design. EADV 2012; 26: 503-507. Go to original source...
    30. Price VH. Treatment of hair loss. N Engl J. Med. 1999; 341-349. Go to original source... Go to PubMed...
    31. Kadry R, Hamadah I. Case reports: Multifocal scalp abscess with subcutaneous fat necrosis and scarring alopecia as a complication of scalp mesotherapy. Journal of Drugs in Dermatology. 2008; 7: 72-73. Go to PubMed...
    32. Tennstedt D, Lachapelle JM. Cutaneous adverse effects of mesotherapy. Ann Dermatol Venereol 1997; 124: 192-196. Go to PubMed...
    33. Kossard S, Lee MS, Wilkinson B. Postmenopausal frontal fibrosing alopecia: a frontal variant of lichen planopilaris. J Am Acad Dermatol 1997; 36: 59-66 Go to original source... Go to PubMed...
    34. Arenberger P, a spol.Klinická trichologie-nemoci vlasů a nové trendy v jejich léčbě, MAXDORF.2002.

    Return to the content


    Dermatology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.